By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Oct 3, 2022/News
The new resource is a quick reference to help PTs, PTAs, and others reduce the risk of transmission in clinical settings.
Dec 16, 2021/Test & Measure
The Multi-Directional Reach Test (MDRT) measures balance and the limits of stability in the anterior-posterior and medial-lateral directions by testing how far an individual can voluntarily reach forward, to the right, to the left, and lean backward, while standing with their feet flat on the ground,
Dec 2, 2017/Test & Measure
This is a self-report questionnaire that measures severity of shortness of breath/dyspnea during various activities of daily living (ADLs) in patients with various forms of lung pathology.
Apr 12, 2021/Review
A global study links significant percentages of dementia, depression, cancer, and stroke to insufficient PA.
Jun 1, 2022/Column
A home visit to a patient with an intriguing background leads a PT back to the profession.
Jan 23, 2018/News
Musculoskeletal diseases aren't just widespread— they've also become a significant factor in the economy, with associated costs estimated at an amount equal to 5.76% of the US gross domestic product. That's just 1 of the insights offered in the latest edition of a detailed report.
Apr 4, 2022/Perspective
CMT is the most common inherited peripheral neuropathy, affecting 10-28 of every 100,000 children.
Aug 16, 2017/Test & Measure
A revised version of the ADRQL was developed based on analyses of the psychometric properties of the original ADRQL and consists of 40 items addressing the same domains.
Apr 19, 2019/Article
Many conditions and impairments encountered by PTs have genetic underpinnings, including diseases such as stroke, arthritis, diabetes, heart disease, and cancer to name a few.
Jun 29, 2017/Test & Measure
A 13-item questionnaire designed to provide both a patient and a caregiver report of the quality of life (QOL) for patients who have been diagnosed with Alzheimer Disease (AD).